Technical420 Site Search

Last week, Khiron announced a major milestone and reported to have successfully completed its first sale of medical cannabis product in Brazil. By leveraging production, distribution, marketing agreements with leading pharmaceutical distributors, and clinical assets in Latin America, Khiron plans to expand its presence in Brazil. One of the reasons…

One of the most important trends in the cannabis sector is related to environmental, social, and governance (ESG) concerns. During the last month, we have seen a significant increase in the number of companies that are focused on addressing these concerns. Going forward, we expect the ESG trend to become…

So far this year, the North American cannabis industry has recorded impressive advancements, and this is a trend that we are closely following. From a conservative US Supreme Court Justice calling cannabis regulation outdated to Mexico's Supreme Court decriminalizing recreational cannabis, we are favorable on the legalization trend and believe…

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , today reiterates its plans to enter the Mexican medical cannabis market in 2021, following a landmark vote by the Mexican…

2021 is proving to be a banner year for Khiron Life Sciences Corp. (TSXV: KHRN) (OTCMKTS: KHRNF) and this is a story that we are closely following. Specifically, we are impressed with how Khiron is capitalizing on emerging international markets in the European Union (EU) as well as in Latin…

Khiron Life Sciences Corp. (TSXV: KHRN)(OTCQX: KHRNF)( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , today announces regulatory and supply chain advances that accelerate Khiron's entry into the Mexican market by several months. Leveraging the Company's designation in Colombia as…

Khiron is capitalizing on strategic medical cannabis markets where several countries have passed legal cannabis legislation. These markets are the European Union (EU) and Latin America (Central and South America). According to Prohibition Partners, the EU and Latin American medical cannabis markets are forecasted to grow at more than 50%…

One of the most exciting aspects of Khiron’s model is related to how it is positioned to disrupt the opioid market in Latin America and the EU. With a combined population of more than 1 billion, we believe these markets represent attractive long-term growth opportunities. Khiron is led by a…

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , is pleased to announce the appointment of Franziska Katterbach as President, Khiron Europe to replace Tejinder Virk , who…

During the last year, we have seen a substantial increase in the number of studies that are being conducted on cannabis. One of the significant areas of focus for the medical cannabis industry is related to how cannabis can replace opioids and we consider this to be an important topic…